Resilience Lab Acquires Options MD

October 8, 2024

Resilience Lab has acquired Options MD, a telepsychiatry company specializing in medication management for treatment-resistant and severe mental illness. The deal brings Options MD's AI-powered intake and decision-support platform and its clinical team into Resilience Lab, allowing the combined business to offer integrated medication management and psychotherapy and to expand services across payer networks in five Northeastern states.

Buyers
Resilience Lab
Targets
Options MD
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.